Insulet(PODD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PODD Insulet

Post-Market Trading 12-18 16:49:00 EST

256.44

-6.91

-2.62%

盘后254.95

-1.49-0.58%

16:46 EST

High262.67	Low256.33	Vol872.50K
Open261.88	D1 Closing263.35	Amplitude2.41%
Mkt Cap17.99B	Tradable Cap17.90B	Total Shares70.14M
T/O226.05M	T/O Rate1.25%	Tradable Shares69.79M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"PODD","market":"US","secType":"STK","nameCN":"Insulet","latestPrice":256.44,"timestamp":1734555600000,"preClose":263.35,"halted":0,"volume":872498,"hourTrading":{"tag":"盘后","latestPrice":254.9499,"preClose":256.44,"latestTime":"16:46 EST","volume":26012,"amount":6668520.859,"timestamp":1734558395088},"delay":0,"floatShares":69789561,"shares":70144775,"eps":5.735722,"marketStatus":"Post-Market Trading","change":-6.91,"latestTime":"12-18 16:49:00 EST","open":261.88,"high":262.67,"low":256.33,"amount":226054093.37323996,"amplitude":0.024074,"askPrice":254.95,"askSize":469,"bidPrice":251.49,"bidSize":1,"shortable":3,"etf":0,"ttmEps":5.735722,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1734570000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1179201600000,"exchange":"NASDAQ","adjPreClose":263.35,"preHourTrading":{"tag":"盘前","latestPrice":263,"preClose":263.35,"latestTime":"09:25 EST","volume":36,"amount":9464.4306,"timestamp":1734531900041},"postHourTrading":{"tag":"盘后","latestPrice":254.9499,"preClose":256.44,"latestTime":"16:46 EST","volume":26012,"amount":6668520.859,"timestamp":1734558395088},"volumeRatio":1.463743,"impliedVol":0.4458,"impliedVolPercentile":0.2659},"requestUrl":"/m/hq/s/PODD","defaultTab":"news","newsList":[{"id":"2492180015","title":"Redburn Atlantic Raises Price Target on Insulet to $300 From $270, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2492180015","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492180015?lang=en_us&edition=fundamental","pubTime":"2024-12-18 23:48","pubTimestamp":1734536936,"startTime":"0","endTime":"0","summary":"Insulet (PODD) has an average rating of overweight and mean price target of $291.48, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PODD"],"gpt_icon":0},{"id":"2491037093","title":"Why Insulet (PODD) is a Top Momentum Stock for the Long-Term","url":"https://stock-news.laohu8.com/highlight/detail?id=2491037093","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491037093?lang=en_us&edition=fundamental","pubTime":"2024-12-13 22:50","pubTimestamp":1734101412,"startTime":"0","endTime":"0","summary":"Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike.Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growth, and momentum. The Style Scores can help you narrow down which stocks are better for your portfolio and which ones can beat the market over the long-term.Is This 1 Momentum Stock a Screaming Buy Right Now?Different than value or growth investors, momentum-oriented investors live by the saying \"the trend is your friend.\" This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.To read this article on Zacks.com click here.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/I67vygGrP1BjgOjVx.apeA--~B/aD03Mjg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/I67vygGrP1BjgOjVx.apeA--~B/aD03Mjg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-insulet-podd-top-momentum-145012952.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1261432733.SGD","BK4585","BK4551","BK4223","BK4566","PDM","LU1084165304.USD","PODD","LU1119994496.HKD","BK4588","BK4082","BK4194"],"gpt_icon":0},{"id":"2491135637","title":"Insulet Is Maintained at Overweight by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2491135637","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491135637?lang=en_us&edition=fundamental","pubTime":"2024-12-13 03:47","pubTimestamp":1734032820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PODD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 12, 2024 14:47 ET (19:47 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PODD"],"gpt_icon":0},{"id":"2491435805","title":"RMD or PODD: Which Is the Better Value Stock Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2491435805","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491435805?lang=en_us&edition=fundamental","pubTime":"2024-12-13 00:40","pubTimestamp":1734021606,"startTime":"0","endTime":"0","summary":"Investors interested in Medical - Products stocks are likely familiar with ResMed  and Insulet . But which of these two companies is the best option for those looking for undervalued stocks?Right now, ResMed is sporting a Zacks Rank of #2 , while Insulet has a Zacks Rank of #3 . This means that RMD's earnings estimate revision activity has been more impressive, so investors should feel comfortable with its improving analyst outlook. However, value investors will care about much more than just this.RMD currently has a forward P/E ratio of 26.33, while PODD has a forward P/E of 85.03. We also note that RMD has a PEG ratio of 1.78. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. PODD currently has a PEG ratio of 4.18.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/e0VWXB5.wUFiKGuJPPpLzg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/e0VWXB5.wUFiKGuJPPpLzg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rmd-podd-better-value-stock-164006272.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","BK4504","LU1084165304.USD","BK4566","BK4567","LU2008162690.USD","RMD.AU","BK4585","LU2177674079.SGD","RMD","BK4588","LU1261432733.SGD","BK4548","PODD","BK4551","LU1119994496.HKD"],"gpt_icon":0},{"id":"2490689483","title":"Insulet Is Maintained at Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2490689483","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490689483?lang=en_us&edition=fundamental","pubTime":"2024-12-12 03:19","pubTimestamp":1733944740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PODD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 11, 2024 14:19 ET (19:19 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PODD"],"gpt_icon":0},{"id":"2490486740","title":"Citigroup Raises Price Target on Insulet to $310 From $283, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2490486740","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490486740?lang=en_us&edition=fundamental","pubTime":"2024-12-12 00:46","pubTimestamp":1733935560,"startTime":"0","endTime":"0","summary":"Insulet (PODD) has an average rating of overweight and mean price target of $283.05, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PODD"],"gpt_icon":0},{"id":"2490686584","title":"Tandem Diabetes, Insulet views Positive at OTR Global after checks","url":"https://stock-news.laohu8.com/highlight/detail?id=2490686584","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490686584?lang=en_us&edition=fundamental","pubTime":"2024-12-11 22:40","pubTimestamp":1733928024,"startTime":"0","endTime":"0","summary":"OTR Global has a Positive read on Tandem Diabetes (TNDM) and Insulet (PODD) after interviews with U.S. endocrinology practitioners that showed new ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tandem-diabetes-insulet-views-positive-at-otr-global-after-checks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tandem-diabetes-insulet-views-positive-at-otr-global-after-checks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","LU1261432733.SGD","PODD","LU1084165304.USD","TNDM","BK4082","BK4588","BK4551","LU1119994496.HKD","BK4585"],"gpt_icon":0},{"id":"2490545853","title":"Wells Fargo Keeps Their Buy Rating on Insulet (PODD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2490545853","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490545853?lang=en_us&edition=fundamental","pubTime":"2024-12-11 19:55","pubTimestamp":1733918139,"startTime":"0","endTime":"0","summary":"Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Insulet (PODD – Research Report) today and set a price target of $305.00. The compan...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wells-fargo-keeps-their-buy-rating-on-insulet-podd?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wells-fargo-keeps-their-buy-rating-on-insulet-podd?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PODD"],"gpt_icon":0},{"id":"2490388073","title":"Dow Jones Futures: Google, Tesla Strong But Palantir, Nvidia Fall Amid Growth Woes","url":"https://stock-news.laohu8.com/highlight/detail?id=2490388073","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490388073?lang=en_us&edition=fundamental","pubTime":"2024-12-11 06:58","pubTimestamp":1733871539,"startTime":"0","endTime":"0","summary":"Google broke out on its Willow quantum computing chip as Tesla races. But that masked underlying weakness in growth stocks again.","market":"us","thumbnail":"https://www.investors.com/wp-content/uploads/2023/12/Stock-quantumcomputer-aigenerated-01-adobe-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2023/12/Stock-quantumcomputer-aigenerated-01-adobe-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-google-tesla-strong-palantir-nvidia-fall-cpi-inflation-due/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["NVDU","UPRO","GEV","SNVD.UK","SH","APP","XLE","SSO","VOO","XLI","NVDX","PLTR","SPXU",".SPX","3NVD.UK","FFTY","SPY","XLV","PODD","JETS","GOOG","QQEW","TSM","ARKG","XHB","NQmain","GOOGL","NVD2.UK","GEV.AU","OEX","TSLA","03145","NVDA","FDN","SMH","XME","IGV","XLF","IVV","AVGO","2NVD.UK","TSLL","NVD3.UK","RSP","NVD","ESmain","NVDS","NVDS.UK"],"gpt_icon":1},{"id":"2490018137","title":"Insulet (PODD) Receives a Buy from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2490018137","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490018137?lang=en_us&edition=fundamental","pubTime":"2024-12-10 21:15","pubTimestamp":1733836516,"startTime":"0","endTime":"0","summary":"In a report released today, Matthew Taylor from Jefferies assigned a Buy rating to Insulet (PODD – Research Report), with a price target of $340.00...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/insulet-podd-receives-a-buy-from-jefferies?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/insulet-podd-receives-a-buy-from-jefferies?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","PODD","BK4566","BK4588","BK4585","BK4082"],"gpt_icon":0},{"id":"2490065030","title":"Insulet Corp : Jefferies Raises Target Price to $340 From $300","url":"https://stock-news.laohu8.com/highlight/detail?id=2490065030","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490065030?lang=en_us&edition=fundamental","pubTime":"2024-12-10 16:03","pubTimestamp":1733817815,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nFWN3NB0MT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4551","BK4566","PODD","BK4588","BK4082"],"gpt_icon":0},{"id":"2490778334","title":"Canaccord Genuity Adjusts Price Target on Insulet to $304 From $269, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2490778334","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490778334?lang=en_us&edition=fundamental","pubTime":"2024-12-09 22:11","pubTimestamp":1733753502,"startTime":"0","endTime":"0","summary":"Insulet (PODD) has an average rating of overweight and mean price target of $280.43, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PODD"],"gpt_icon":0},{"id":"2490720497","title":"Should You Continue to Retain Insulet Stock in Your Portfolio Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2490720497","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490720497?lang=en_us&edition=fundamental","pubTime":"2024-12-09 20:22","pubTimestamp":1733746920,"startTime":"0","endTime":"0","summary":"Insulet Corporation’s PODD rapid progress with its strategic imperatives on Omnipod platform is poised to help it grow in the upcoming quarters. The largely untapped diabetes market also presents promising opportunities to grow, both in Type 1 and 2 indications. Besides, a sound financial position bodes well for the stock. Meanwhile, adverse macroeconomic impacts as well as reliance on a single platform raise concerns for Omnipod’s operations.In the past year, this Zacks Rank #3  stock has increased 36%, outperforming the industry’s 36% growth and S&P 500 composite’s gain of 32%.The developer, manufacturer and distributor of insulin delivery systems has a market capitalization of $17.56 billion. PODD’s earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 3.41%.Find the latest earnings estimates and surprises on the ZacksEarnings Calendar.Strong Solvency but Leveraged Balance Sheet:Insulet exited the third quarter of 2024 with cash and ca","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Z2Y2lgbJQfUa74IVYcsxPA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Z2Y2lgbJQfUa74IVYcsxPA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/continue-retain-insulet-stock-portfolio-122200390.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1791710400.SGD","LU1057294990.SGD","LU0106261612.USD","LU2112291526.USD","BK4504","IE00B4R5TH58.HKD","BK4082","LU1989764748.USD","IE00BJT1NW94.SGD","LU1983299246.USD","LU2506951958.HKD","LU0882574055.USD","LU1989772840.SGD","LU2506952170.USD","LU0345769128.USD","LU0950375773.USD","BK4551","LU2087625088.SGD","LU2362541513.USD","PAHC","PODD","LU1791710582.SGD","LU0077335932.USD","LU1023059063.AUD","LU2506952097.USD","LU1804176565.USD","LU2265009873.SGD","LU2362541273.HKD","BK4581","BK4198","LU0823417737.USD","LU0187121727.USD","LU0122379950.USD","LU0528227936.USD","LU0823416689.USD","IE00BLDYK493.USD","IE00B2B36J28.USD","HAE","LU1989772923.USD","LU0353189763.USD","IE00BFTCPJ56.SGD","LU2491050154.USD","BK4588","BSX","LU0238689110.USD","LU1169589451.USD","BK4566","LU1718418525.SGD","LU0205194284.USD"],"gpt_icon":1},{"id":"2490717769","title":"Insulet Corp : Canaccord Genuity Raises Target Price to $304 From $269","url":"https://stock-news.laohu8.com/highlight/detail?id=2490717769","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490717769?lang=en_us&edition=fundamental","pubTime":"2024-12-09 16:05","pubTimestamp":1733731543,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nFWN3NA0MC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4551","PODD","BK4585","BK4566","BK4588","BK4082"],"gpt_icon":0},{"id":"2489404562","title":"Analysts’ Top Healthcare Picks: Insulet (PODD), Monte Rosa Therapeutics (GLUE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2489404562","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489404562?lang=en_us&edition=fundamental","pubTime":"2024-12-06 17:50","pubTimestamp":1733478611,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Insulet (PODD – Research Report) and Monte Rosa Ther...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-insulet-podd-monte-rosa-therapeutics-glue?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-insulet-podd-monte-rosa-therapeutics-glue?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4082","BK4551","HCSG","BK4539","BK4137","BK4139","BK4585","BK4566","PODD","GLUE"],"gpt_icon":0},{"id":"2489846938","title":"Insulet wins $452 mln US verdict against EOFlow in insulin pump secrets case","url":"https://stock-news.laohu8.com/highlight/detail?id=2489846938","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489846938?lang=en_us&edition=fundamental","pubTime":"2024-12-05 23:59","pubTimestamp":1733414374,"startTime":"0","endTime":"0","summary":"Insulet wins $452 mln US verdict against EOFlow in insulin pump secrets caseBy Blake Brittain Dec 5 (Reuters) - Medical device maker Insulet PODD.O convinced a jury that Korean rival EOFlow 294090.KQ ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241205:nL6N3N60I2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2028103732.USD","BK4551","IE00BFXG1179.USD","BK4566","IE00BQXX3F31.USD","LU2089284900.SGD","LU0162691827.USD","PODD","IE00BQXX3C00.GBP","LU0158827948.USD","LU2023251221.USD","MDT","LU0976567544.SGD","LU1291159041.SGD","LU0496365809.HKD","LU0072461881.USD","LU1989764664.SGD","BK4082","LU0211326839.USD","LU1989764748.USD","LU2271345857.HKD","LU0208291251.USD","LU0211331839.USD","IE00B3T34201.USD","LU2111349929.HKD","IE00BQXX3D17.EUR","LU0211326755.USD","LU1571399168.USD","LU2089283258.USD","LU0320765489.SGD","BK4585","LU1989771016.USD","BK4588","LU0070302665.USD","LU0158827781.USD","BK4533"],"gpt_icon":0},{"id":"2489617435","title":"EOFlow Ordered to Pay $452 Million to US-based Insulet for Trade Secret Misuse","url":"https://stock-news.laohu8.com/highlight/detail?id=2489617435","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489617435?lang=en_us&edition=fundamental","pubTime":"2024-12-05 18:12","pubTimestamp":1733393527,"startTime":"0","endTime":"0","summary":"The US District Court for the District of Massachusetts ordered EOFlow  to pay $452 million to Massachusetts-based medical device company Insulet Corporation in damages for misappropriating the latter's trade secrets.The fine comprises $170 million in compensation and $282 million exemplary for willful misappropriation. The South Korean smart wearable drug delivery solution provider's ability to pay the amount remains unclear, according to a press release by Insulet on Wednesday.Shares of EOFlow plunged nearly 30% at market close on Thursday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4551","BK4566","PODD","BK4588","BK4082"],"gpt_icon":0},{"id":"2489407140","title":"BRIEF-Insulet Successfully Defends Its Intellectual Property Against Eoflow","url":"https://stock-news.laohu8.com/highlight/detail?id=2489407140","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489407140?lang=en_us&edition=fundamental","pubTime":"2024-12-05 05:32","pubTimestamp":1733347962,"startTime":"0","endTime":"0","summary":"BRIEF-Insulet Successfully Defends Its Intellectual Property Against EoflowDec 4 (Reuters) - Insulet Corp PODD.O:INSULET SUCCESSFULLY DEFENDS ITS INTELLECTUAL PROPERTY AGAINST EOFLOW CO. IN U.S. DISTR","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241204:nFWN3N51XN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4551","BK4082","PODD","BK4585","BK4566"],"gpt_icon":0},{"id":"2489140968","title":"Insulet Successfully Defends Its Intellectual Property Against Eoflow Co. in U.S. District Court","url":"https://stock-news.laohu8.com/highlight/detail?id=2489140968","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489140968?lang=en_us&edition=fundamental","pubTime":"2024-12-05 05:28","pubTimestamp":1733347685,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241204:nFWN3N51XN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BK4566","BK4551","BK4585","PODD","BK4588"],"gpt_icon":0},{"id":"2489140957","title":"Insulet Corp - Jury Awards Co $452M in Damages","url":"https://stock-news.laohu8.com/highlight/detail?id=2489140957","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489140957?lang=en_us&edition=fundamental","pubTime":"2024-12-05 05:28","pubTimestamp":1733347685,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241204:nFWN3N51XN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","PODD","BK4551","BK4566","BK4588","BK4585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.insulet.com","stockEarnings":[{"period":"1week","weight":-0.0416},{"period":"1month","weight":0.0124},{"period":"3month","weight":0.1154},{"period":"6month","weight":0.3213},{"period":"1year","weight":0.2563},{"period":"ytd","weight":0.2137}],"compareEarnings":[{"period":"1week","weight":0.0025},{"period":"1month","weight":0.0317},{"period":"3month","weight":0.0764},{"period":"6month","weight":0.1047},{"period":"1year","weight":0.2804},{"period":"ytd","weight":0.2714}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.588235,"avgChangeRate":-0.004443},{"month":2,"riseRate":0.470588,"avgChangeRate":-0.007181},{"month":3,"riseRate":0.705882,"avgChangeRate":0.01102},{"month":4,"riseRate":0.470588,"avgChangeRate":0.022014},{"month":5,"riseRate":0.411765,"avgChangeRate":0.011414},{"month":6,"riseRate":0.833333,"avgChangeRate":0.053082},{"month":7,"riseRate":0.388889,"avgChangeRate":-0.010839},{"month":8,"riseRate":0.777778,"avgChangeRate":0.06814},{"month":9,"riseRate":0.555556,"avgChangeRate":0.016235},{"month":10,"riseRate":0.5,"avgChangeRate":-0.011455},{"month":11,"riseRate":0.666667,"avgChangeRate":0.085243},{"month":12,"riseRate":0.444444,"avgChangeRate":0.040182}],"exchange":"NASDAQ","name":"Insulet","nameEN":"Insulet"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Insulet(PODD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Insulet(PODD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Insulet,PODD,Insulet股票,Insulet股票老虎,Insulet股票老虎国际,Insulet行情,Insulet股票行情,Insulet股价,Insulet股市,Insulet股票价格,Insulet股票交易,Insulet股票购买,Insulet股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Insulet(PODD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Insulet(PODD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction